# NeuroBionics

> Seamless interfaces for research and medicine


## Posts

- [NeuroBionics Announces Oversubscribed $10M Seed Round with Second Close Led by Future Ventures](https://neurobionics.io/press/news/neurobionics-announces-oversubscribed-10m-seed-round-with-second-close-led-by-future-ventures/): Financing strengthens momentum as the company advances its endovascular neuromodulation platform toward first-in-human studies. NeuroBionics today announced the completion of its oversubscribed seed round, marking significant momentum as the company advances its endovascular neuromodulation platform toward first-in-human studies. The second close was led by Future Ventures, with participation from Vanedge Capital, LionHeart Ventures, Gaingels, and Opus 44. This follows an earlier close led by Dolby Family Ventures that enabled the company to advance its clinical device and preclinical program. The combined financing brings total funding to $10M and reflects continued support from both new and existing investors. Grounded in a […]
- [NeuroBionics is featured in TechCrunch](https://neurobionics.io/press/neurobionics-is-featured-in-techcrunch/): We’re thrilled to be featured in TechCrunch, spotlighting NeuroBionics’ mission to transform neuromodulation therapy! Our bioelectric fibers, as thin as a human hair, offer a minimally invasive alternative to traditional deep brain stimulation, potentially transforming the treatment of neurological conditions like depression, epilepsy, and Parkinson’s. Built on over a decade of MIT research, our technology uses carbon nanotubes for longer-lasting, safer, and MRI-compatible electrodes. With an oversubscribed Seed Round of $5M funding led by Dolby Family Ventures, we’re advancing toward clinical trials to bring this breakthrough to patients. Read the full article on TechCrunch
- [NeuroBionics Secures an Oversubscribed $5M Seed Round to Advance Endovascular Neuromodulation Technology](https://neurobionics.io/press/neurobionics-seed-press-release/)
- [MIT delta v Demo Day](https://neurobionics.io/press/mit-delta-v-demo-day/): NeuroBionics Pitching at MIT delta v Demo Day In September of 2023, NeuroBionics pitched at MIT delta v Demo Day. Demo Day is the culmination of the intensive three-month incubator program, delta v. NeuroBionics presented to an audience of over 1,200 people including investors, mentors, MIT students, and potential customers. View our pitch here.
- [LabCentral Ignite Golden TicketTesting](https://neurobionics.io/press/labcentral-ignite-golden-tickettesting/): Nicki Driscoll, PhD, wins $50k worth of lab space Nicki competed in the LabCentral Ignite Golden Ticket pitch competition for women founders and won $50,000 worth of lab space at LabCentral for a year. We are thrilled to join the LabCentral community and contribute our vision to the vibrant ecosystem. A massive thank you to LabCentral and the sponsors Alira Health, Amgen, Bristol Myers Squibb, EisnerAmper, Pfizer, Takeda, Novartis, Wilson Sonsini Goodrich & Rosati for providing this remarkable opportunity and for supporting and empowering women founders in the world of innovation and entrepreneurship. 

## Pages

- [Cookie Policy](https://neurobionics.io/cookie-policy/)
- [Privacy Policy](https://neurobionics.io/privacy-policy/)
- [Press & News](https://neurobionics.io/press/)
- [Our Team](https://neurobionics.io/about/our-team/)
- [Contact](https://neurobionics.io/contact/)
- [About](https://neurobionics.io/about/)
- [Research](https://neurobionics.io/research/)
- [Clinical](https://neurobionics.io/clinical/)
- [Scientific Publications](https://neurobionics.io/neurotechnology/scientific-publications/)
- [IO Fiber](https://neurobionics.io/research/io-fiber/)
- [evStim](https://neurobionics.io/clinical/evstim/)
- [Technology](https://neurobionics.io/neurotechnology/)
- [NeuroBionics](https://neurobionics.io/)


[comment]: # (Generated by Hostinger Tools Plugin)